spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Breast Cancer Test 

 HSMN NewsFeed - 9 Oct 2018
Agendia Announces Level 1 Inclusion of MammaPrint(R) Breast Cancer Test in Updated National Comprehensive Cancer Network(R) (NCCN) Guidelines
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 18 Sep 2018
Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
Diagnostics Personalized Medicine Oncology Product Launch
 HSMN NewsFeed - 1 May 2018
Agendia's MammaPrint(R) Receives Positive Coverage Decisions from Three Major Private Healthcare Insurers
Diagnostics Personalized Medicine Oncology Reimbursement
 HSMN NewsFeed - 19 Dec 2017
Agendia and Bluebee Partner to Bring New NGS-based MammaPrint(R) BluePrint(R) Breast Cancer Kit to Market
Diagnostics Personalized Medicine Oncology Product Launch
 HSMN NewsFeed - 9 Dec 2016
Genomic Health Announces Results from Multiple Oncotype DX(R) Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 15 Apr 2014
Eventus Diagnostics Completes $2.72 Million Financing To Support Commercialization Of Its Octava(TM) Blood Tests For Breast Cancer Detection
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 17 Feb 2014
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
Diagnostics Oncology
 HSMN NewsFeed - 29 Jan 2014
Genomic Health Announces Results of Oncotype DX(R) Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium
Diagnostics Oncology
 HSMN NewsFeed - 1 Oct 2013
Genomic Health Announces Presentation of Oncotype DX(R) Studies Reinforcing Value of Tests in Guiding Treatment for Multiple Cancers
Diagnostics Oncology
 HSMN NewsFeed - 6 Dec 2011
Agendia Introduces the SYMPHONY(TM) Breast Cancer Profile With Paraffin Embedded Tissue
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 25 Jul 2011
St. Gallen International Breast Cancer Expert Panel Guidelines Include Oncotype DX(R) as Predictor of Chemotherapy Benefit
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 12 Jul 2010
Clarient Announces Publication of Mammostrat(R) Breast Cancer Study in Breast Cancer Research
Diagnostics Oncology
 HSMN NewsFeed - 21 Jan 2010
Genomic Health Announces Worldwide Availability of the Oncotype DX(R) Colon Cancer Test
Diagnostics Oncology
 HSMN NewsFeed - 5 May 2009
Clarient Launches New Breast Cancer Test
Diagnostics Oncology
 HSMN NewsFeed - 5 Feb 2009
Breast Cancer Clinical Results Show Test Can Differentiate Normal, Early and Later Stage Cancers
Diagnostics Oncology
 HSMN NewsFeed - 4 Feb 2009
Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
Diagnostics Oncology
 HSMN NewsFeed - 12 Dec 2008
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 28 Oct 2008
Ikonisys Receives FDA Clearance for Non-Invasive, HER-2 Breast Cancer Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 15 Sep 2008
Invitrogen, Biocare to Market FDA Approved Breast Cancer Test
Diagnostics FDA
 HSMN NewsFeed - 4 Sep 2008
Agendia Launches TargetPrint(R) for Breast Cancer Patients
Diagnostics Oncology
 HSMN NewsFeed - 21 Apr 2008
Power3 Medical Products Issues Letter to Shareholders
Diagnostics
 HSMN NewsFeed - 17 Dec 2007
MammaPrint(R) Breast Cancer Test Shown To Be Powerful Tool for Prognosis Prediction in Postmenopausal Breast Cancer Patients
Diagnostics Oncology
 HSMN NewsFeed - 14 Dec 2007
Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen
Diagnostics Oncology
 HSMN NewsFeed - 16 Jul 2007
PreMD Signs Marketing and Distribution Agreement with AstraZeneca
Diagnostics Cardiology Licensing Distribution
 HSMN NewsFeed - 6 Jun 2007
PreMD Submits 510(k) to the FDA for Expanded Regulatory Claim for PREVU(x) POC
Diagnostics FDA
 HSMN NewsFeed - 25 Apr 2007
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
Diagnostics Oncology Licensing
 HSMN NewsFeed - 13 Mar 2007
PreMD Provides Update on 510(k) Application for PREVU(x) LT
Diagnostics FDA
 HSMN NewsFeed - 27 Sep 2006
PreMD's PREVU(x) LT Cleared For Sale in Canada
Diagnostics Cardiology Regulatory
 HSMN NewsFeed - 18 Sep 2006
PreMD's PREVU(x) LT Cleared For Sale in Europe
Diagnostics Cardiology Regulatory
Return to NewsFeed  

 Additional items found! 11

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 11 additional stories matching:
Breast Cancer Test
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!